Susquehanna Portfolio Strategies
FULC icon

Susquehanna Portfolio Strategies’s Fulcrum Therapeutics FULC Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
85,580
+66,259
+343% +$403K 0.01% 740
2026
Q1 		$148K Buy
+19,321
New +$179K ﹤0.01% 920
2024
Q3 		– Sell
-81,217
Closed -$504K – 410
2024
Q2 		$504K Sell
81,217
-87,558
-52% -$663K 0.02% 365
2024
Q1 		$1.59M Hold
168,775
– – 0.04% 368
2023
Q4 		$1.14M Buy
+168,775
New +$749K 0.02% 566

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Susquehanna Portfolio Strategies's FULC Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Fulcrum Therapeutics (FULC) stake by 343% in Q2 2026, buying an estimated $403K and bringing the position to 85,580 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #740.

Susquehanna Portfolio Strategies first reported a position in FULC in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.59M in Q1 2024. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Susquehanna Portfolio Strategies held 85,580 shares of Fulcrum Therapeutics worth $313K as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 66,259 Fulcrum Therapeutics shares in Q2 2026, an estimated $403K.
  • Fulcrum Therapeutics made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #740 holding.
  • Susquehanna Portfolio Strategies first reported a position in Fulcrum Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Fulcrum Therapeutics position peaked at $1.59M in Q1 2024.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.